Quia Pharma AB (publ)
STO: QUIA.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard Glimstedt
- Employees
- 3
- Headquarters
- Uppsala, Sweden
- IPO year
- 2005
- Market cap
- SEK 1.3M
- Website
- https://www.quiapeg.com
Loading QUIA…
Loading profile data…Frequently asked questions about QUIA
What does Quia Pharma AB (publ) (QUIA.ST) do?
QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.
Where does QUIA.ST trade?
Quia Pharma AB (publ) (QUIA.ST) trades on the Stockholm Stock Exchange.
What sector is QUIA.ST in?
Quia Pharma AB (publ) (QUIA.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Quia Pharma AB (publ)?
Richard Glimstedt is the chief executive officer of Quia Pharma AB (publ) (QUIA.ST).
Where is Quia Pharma AB (publ) headquartered?
Quia Pharma AB (publ) is headquartered in Sweden.
Does QUIA.ST pay a dividend?
Quia Pharma AB (publ) (QUIA.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QUIA.ST go public?
Quia Pharma AB (publ) (QUIA.ST) completed its initial public offering in 2005.